208 related articles for article (PubMed ID: 25914531)
1. Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients.
Nagai K; Makita H; Suzuki M; Shimizu K; Konno S; Ito YM; Nishimura M;
Int J Chron Obstruct Pulmon Dis; 2015; 10():745-57. PubMed ID: 25914531
[TBL] [Abstract][Full Text] [Related]
2. Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.
Jones PW; Anderson JA; Calverley PM; Celli BR; Ferguson GT; Jenkins C; Yates JC; Vestbo J; Spencer MD;
Respir Res; 2011 May; 12(1):71. PubMed ID: 21627828
[TBL] [Abstract][Full Text] [Related]
3. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.
Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
[TBL] [Abstract][Full Text] [Related]
5. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
6. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.
Nishimura M; Makita H; Nagai K; Konno S; Nasuhara Y; Hasegawa M; Shimizu K; Betsuyaku T; Ito YM; Fuke S; Igarashi T; Akiyama Y; Ogura S;
Am J Respir Crit Care Med; 2012 Jan; 185(1):44-52. PubMed ID: 22016444
[TBL] [Abstract][Full Text] [Related]
7. Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes.
Zhang JQ; Zhang JQ; Liu H; Zhao ZH; Fang LZ; Liu L; Fu WP; Shu JK; Feng JG; Dai LM
Int J Chron Obstruct Pulmon Dis; 2015; 10():917-23. PubMed ID: 25999707
[TBL] [Abstract][Full Text] [Related]
8. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
[TBL] [Abstract][Full Text] [Related]
9. Quality of life, forced expiratory volume in one second and body mass index in patients with COPD, during therapy for controlling the disease.
Stojkovic J; Stevcevska G
Prilozi; 2009 Jul; 30(1):129-42. PubMed ID: 19736536
[TBL] [Abstract][Full Text] [Related]
10. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
[TBL] [Abstract][Full Text] [Related]
11. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
12. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
14. The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.
Martin AL; Marvel J; Fahrbach K; Cadarette SM; Wilcox TK; Donohue JF
Respir Res; 2016 Apr; 17():40. PubMed ID: 27084761
[TBL] [Abstract][Full Text] [Related]
15. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
16. Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R
Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study.
Suzuki M; Makita H; Ito YM; Nagai K; Konno S; Nishimura M;
Eur Respir J; 2014 May; 43(5):1289-97. PubMed ID: 24232696
[TBL] [Abstract][Full Text] [Related]
18. Behavior of Quality of Life (SGRQ) in COPD Patients According to BODE Scores.
Nonato NL; Díaz O; Nascimento OA; Dreyse J; Jardim JR; Lisboa C
Arch Bronconeumol; 2015 Jul; 51(7):315-21. PubMed ID: 25622995
[TBL] [Abstract][Full Text] [Related]
19. Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease.
Nishijima Y; Minami S; Yamamoto S; Ogata Y; Koba T; Futami S; Komuta K
Int J Chron Obstruct Pulmon Dis; 2015; 10():439-44. PubMed ID: 25767381
[TBL] [Abstract][Full Text] [Related]
20. Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data.
Halpin DM; Peterson S; Larsson TP; Calverley PM
Respir Med; 2008 Nov; 102(11):1615-24. PubMed ID: 18691861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
